VERTEX PHARMACEUTICALS INC / MA Derivative Liability, Not Offset, Policy Election Deduction
VERTEX PHARMACEUTICALS INC / MA (VRTX) had Derivative Liability, Not Offset, Policy Election Deduction of $1.77 million as of 2016-09-30, per its 10-Q filed 2016-10-31.
Discontinued › Notes › Offsetting › Offsetting Derivative Liabilities › Derivative Liability, Subject to Master Netting Arrangement, after Offset and Deduction
us-gaap:DerivativeLiabilityNotOffsetPolicyElectionDeduction · last filed 2016-10-31
- 2016-09-30: Derivative Liability, Not Offset, Policy Election Deduction $1.77M.
- 2016-06-30: Derivative Liability, Not Offset, Policy Election Deduction $7.41M.
- 2016-03-31: Derivative Liability, Not Offset, Policy Election Deduction $3.84M.
- 2015-12-31: Derivative Liability, Not Offset, Policy Election Deduction $901.00K.
| Period end | Derivative Liability, Not Offset, Policy Election Deduction |
|---|---|
| 2016-09-30 | $1.77M 10-Q · filed 2016-10-31 |
| 2016-06-30 | $7.41M 10-Q · filed 2016-08-01 |
| 2016-03-31 | $3.84M 10-Q · filed 2016-05-03 |
| 2015-12-31 | $901.00K 10-Q · filed 2016-10-31 |
| 2015-09-30 | $1.58M 10-Q · filed 2015-10-30 |
| 2015-06-30 | $1.09M 10-Q · filed 2015-08-04 |
| 2015-03-31 | $617.00K 10-Q · filed 2015-05-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |